Corneal transparency requires a high level of organization of stromal collagen fibrils. Proteoglycans are well known to play a critical role in the formation of such a well organized collagen matrix that accounts for corneal strength and transparency. Corneal keratan sulfate proteoglycans, i.e., lumican (Lum), keratocan (Kera) and mimecan (Mime), belong to small leucine-rich repeat proteoglycans (SLRP) family. Results of our previous studies suggest that individual KSPGs have distinct roles in maintaining corneal transparency. Like other SLRP proteins, lumican serves as a regulator of collagen fibrillogenesis. Ever increasing evidence indicate that lumican is a matrikine that binds to cell surface receptor(s) to exert its effects on multiple cellular functions such as epithelial cell migration and proliferation during corneal wound healing, metastasis of tumor cells, induction of epithelial-mesenchyme transition (EMT) of injured lens, and regulation of keratocan gene (Kera) expression. We hypothesize the molecular mechanism accountable for regulating stromal collagen matrix formation and cellular functions by lumican arises from unique amino acid sequences of specific domains of the core protein. The proposed studies are to further determine the structure/function relationships of lumican in respect to collagen fibrillogenesis, Kera expression, and to isolate and characterize lumican receptor(s).
Specific Aim 1 A, 1B and 1C will define structure/function relationship of lumican in vivo by intrastromal lumican Plasmid DNA injection, i.e., pSecLumY20F (Y20 residue substituted by F), Y22F, Y20FY22F, and C41S and C295S, and N88T, N160T and N252T, to Lum-/- mice. The synthesis and secretion of such lumican mutant proteins will be determined by western blot and immunohistochemistry analysis to determine the roles of N- and C-terminal domains and modification of KS- GAG chain of lumican molecules on collagen fibrillogenesis in vivo, respectively.
Aim 1 D is to further define structure/function of lumican binding collagen in vitro with purified recombinant proteins encoded by the above plasmids.
Specific Aim 2 is to determine lumican domains that are capable of enhancing keratocan expression with plasmids encoding fusion lumican/keratocan domains by stroma injection of Lum-/- mice.
In Specific Aim 3, lumican receptor(s) from keratocytes and macrophages will be isolated and characterized. The domains of lumican identified to be active in these diverse functions can then be tested for potential use in treating diseases involving lumican, e.g., persistent and excessive inflammation, corneal transparency of injured cornea, improved wound healing of diabetes, etc.

Agency
National Institute of Health (NIH)
Institute
National Eye Institute (NEI)
Type
Research Project (R01)
Project #
5R01EY011845-08
Application #
7677302
Study Section
Anterior Eye Disease Study Section (AED)
Program Officer
Shen, Grace L
Project Start
2006-09-01
Project End
2011-08-31
Budget Start
2009-09-01
Budget End
2010-08-31
Support Year
8
Fiscal Year
2009
Total Cost
$440,533
Indirect Cost
Name
University of Cincinnati
Department
Ophthalmology
Type
Schools of Medicine
DUNS #
041064767
City
Cincinnati
State
OH
Country
United States
Zip Code
45221
Call, Mindy; Meyer, Ewa Anna; Kao, Winston W et al. (2018) Hair Follicle Stem Cell Isolation and Expansion. Bio Protoc 8:
Dong, Fei; Jin, Xueting; Boettler, Michelle A et al. (2018) A Mouse Model of Schnyder Corneal Dystrophy with the N100S Point Mutation. Sci Rep 8:10219
Dong, Fei; Call, Mindy; Xia, Ying et al. (2017) Role of EGF receptor signaling on morphogenesis of eyelid and meibomian glands. Exp Eye Res 163:58-63
Gesteira, Tarsis Ferreira; Coulson-Thomas, Vivien J; Yuan, Yong et al. (2017) Lumican Peptides: Rational Design Targeting ALK5/TGFBRI. Sci Rep 7:42057
Coulson-Thomas, Vivien J; Coulson-Thomas, Yvette M; Gesteira, Tarsis F et al. (2016) Extrinsic and Intrinsic Mechanisms by Which Mesenchymal Stem Cells Suppress the Immune System. Ocul Surf 14:121-34
Kao, Winston W-Y; Coulson-Thomas, Vivien J (2016) Cell Therapy of Corneal Diseases. Cornea 35 Suppl 1:S9-S19
Castillo, Eliseo F; Zheng, Handong; Van Cabanlong, Christian et al. (2016) Lumican negatively controls the pathogenicity of murine encephalitic TH17 cells. Eur J Immunol 46:2852-2861
Dong, Fei; Liu, Chia-Yang; Yuan, Yong et al. (2015) Perturbed meibomian gland and tarsal plate morphogenesis by excess TGF? in eyelid stroma. Dev Biol 406:147-57
Coulson-Thomas, Vivien Jane; Chang, Shao-Hsuan; Yeh, Lung-Kun et al. (2015) Loss of corneal epithelial heparan sulfate leads to corneal degeneration and impaired wound healing. Invest Ophthalmol Vis Sci 56:3004-14
Coulson-Thomas, Vivien Jane; Gesteira, Tarsis Ferreira; Esko, Jeffrey et al. (2014) Heparan sulfate regulates hair follicle and sebaceous gland morphogenesis and homeostasis. J Biol Chem 289:25211-26

Showing the most recent 10 out of 58 publications